Christopher D. Thibodeau Email & Phone Number

Vesica Health is a commercial-stage molecular diagnostics company focused on improving the early detection and management of bladder cancer. Vesica has translated two decades of advanced biomarker research in bladder cancer into a well-validated, clinically actionable test that enhances the evaluation of hematuria, early detection of disease, and recurrence monitoring. Vesica’s patented, noninvasive urine-based AssureMDx test helps physicians accurately triage hematuria patients, distinguishing those at increased risk for bladder cancer, who may benefit from immediate referral to urology and clinical evaluation, from those at very low risk, who may safely avoid invasive procedures. AssureMDx test helps urologists noninvasively monitor bladder cancer patients at increased risk of recurrence after initial treatment, thereby improving patient management and outcomes.

Genuity Health, Inc. focuses on delivering novel analytic tools to facilitate deeper insights into the human genome. With the burgeoning field of genomic testing outpacing the bandwidth of the genetics community, there is a growing need for intelligent applications to provide accurate and more efficient analysis of genotypes and the resulting phenotypes. Genuity's mission is to help patients, and their physicians, leverage genomic information to make more informed decisions and improve health outcomes.

Immunis.AI is a privately held immunogenomic 'liquid biopsy' platform company dedicated to the early detection of cancer and other diseases at the critical point of immune escape, when the opportunity for cure is at its greatest. The company's patented Intelligentia™ platform leverages the power of the immune system, RNA sequencing technology, and machine learning to develop disease-specific algorithms. This proprietary approach involves comparing the differential gene expression patterns from two immune cells, using the patient as their own control. This method normalizes and enhances the signal of the underlying pathology, providing individualized diagnostic, prognostic, therapeutic response, and disease monitoring assessments.

Irvine, Ca, Us

MDxHealth is a molecular diagnostics company that develops and commercializes advanced molecular tests for the assessment and personalized treatment of cancer patients. MDxHealth has a large portfolio of proprietary genomic tests that aid physicians in the diagnosis and prognosis of cancer, as well as the prediction of therapeutic response. The Company leverages Epigenetic, Next Gen and Deep Targeted Sequencing technologies for biomarker identification and partners with pharmaceutical and leading academic institutions on the development and validation of companion diagnostic assays. MDxHealth’s European headquarters are located in Herstal, Belgium and its US headquarters and CAP/CLIA laboratory operations are located in Irvine, California. Reporting to the CEO, and a member of the corporate Executive Management Team with P&L responsibility for US operations. Provide oversight of Commercial Operations, Laboratory Operations, Medical Affairs, Clinical Affairs, Human Resources and Information Technology departments, and coordination between R&D, Product Development, Finance, Legal and Regulatory departments on the day-to-day product development, operational and commercialization activities. Charged with establishing and executing on the short, mid and long-term corporate goals, to effectively capture market share, improve operational efficiency and increase shareholder value. Report quarterly to the Board of Directors on corporate initiatives and achievements.

Irvine, Ca, Us

Reporting to the CEO, and a member of the Executive Management Team with responsibility for global commercial operations and departmental responsibilities including clinical affairs, medical affairs, managed care, billing & collections, business development, sales and marketing. Provide oversight of Commercial Operations on product development, operational and commercialization activities to improve productivity and efficiency while achieving corporate goals. Perform market research and opportunity assessment; establish product specifications development and conduct validation studies for successful launch and reimbursement of tests. Report quarterly to the Board of Directors on corporate initiatives and achievements.Key Team Achievements: • Developed and executed strategic business plan for the development and commercial launch of the company’s flagship ConfirmMDx for Prostate Cancer test• Established US commercial operations and CAP/CLIA/ISO laboratory operations in Irvine• Assisted in several rounds of successful fundraising, in excess of $100M• Obtained Local Coverage Determination (LCD) establishing Medicare reimbursement for ConfirmMDx• Gained inclusion of ConfirmMDx in the NCCN Guidelines • Awarded unique Tier 1 MAAA CPT code for ConfirmMDx• Awarded Government Services Agreement for ConfirmMDx and placement on the Federal Supply Schedule • Captured national contract for ConfirmMDx with Kaiser Permanente

Irvine, Ca, Us

Agendia is a leader in gene expression profiling, providing microarray-based genomic tests to physicians and their patients, as well as pharmaceutical, government and academic research institutions. Through its CAP and CLIA certified laboratories, Agendia offers the MammaPrint breast cancer recurrence assay, the first and only FDA-cleared IVDMIA test, as a LDT service to surgeons, medical oncologists and pathologists worldwide. Responsible for directing global marketing initiatives for Agendia; leading strategic and tactical planning for the successful promotion of Agendia’s tests. Chair of the New Product Development Committee coordinating efforts between R&D, Operations, Scientific, Medical and Regulatory staff on the development and commercialization of Agendia’s core product offering. Coordinated with Key Opinion Leading (KOLs) physicians and Executive Management team to define the product roadmap in the long, mid and short-term to address market opportunities. Managed trade shows, sales collateral, advertising, Advisory Board meetings, Speakers Bureau, sales training and more. Directed Marketing Staff and Customer Service department. Key Team Achievements: • Directed the successful US launch of Agendia’s lead product MammaPrint• Developed strategic marketing plan for the company’s portfolio of services, covering market segmentation, value proposition, positioning, branding, channel and communications strategy • Successfully launched the TargetPrint ER/PR/HER2 by gene expression, Research Gene Panel with 56 novel drug targets and BluePrint the first molecular intrinsic sub-typing profile for breast cancer

Salt Lake City, Utah, Us

Numira is a specialty R&D tools company focused on leveraging advances in genetics and molecular imaging with a portfolio of novel imaging products and testing services that provide researchers with unprecedented insight into genomics, developmental biology, mechanisms of disease, drug efficacy and toxicity. Recruited as the second employee of the company pre-Series A, reporting to the CEO and Board of Directors. Tasked with establishing Numira’s brand, building the commercial operations team and driving revenue growth. Marketing initiatives focused on new product development; translating drug discovery investigator needs into service offerings through collaboration with the R&D, Software Development and Lab Operations teams. Key Team Accomplishments: • Worked in concert with Numira’s CEO and Board of Directors on successful Series A fund raising• Established key relationships with National Institute of Health including: NCI, NIEHS and USEPA • Established a strategic partnership with Charles River Laboratories, the largest domestic preclinical CRO• Forged new business relationships with Amgen, Allergan, Pfizer, Schering-Plough, Merck, Johnson & Johnson, Bristol Meyers Squibb, Genentech, Roche and several top 20 academic cancer centers

Us

US LABS-Esoterix, a subsidiary of Laboratory Corporation of America, is a leading national esoteric, cancer reference testing laboratory specializing in anatomic and molecular pathology and servicing pathologists and oncologists. Managed a national sales team of fifty-two sales representatives and managers: nine Regional and District Sales Managers, forty Anatomic Pathology Specialists, the National Sales Trainer and Sales Administration. Responsibilities included: preparation and attainment of annual revenue forecast for Oncology Testing Division (USLABS, Esoterix, CMBP and Dianon), monthly forecasting, jeopardy analysis, pricing, T&E oversight, commission structure, stack rankings; national sales meeting and training programs.Key Team Achievements:• Successfully led sales team through LabCorp acquisition simultaneously increasing sales by 18% for 2005 over previous year• Successfully managed merger of Esoterix AP/Oncology testing sales force with US LABS team• Successfully managed the transition of over 800 customers and approximately $50M in revenue from Esoterix, Dianon, and CMBP between sales forces with 96% retention• Successfully coordinated the customization and implementation of Microsoft CRM to the Sales Force

Us

Led the Western United States sales team consisting of a District Manager and seven Anatomic Pathology Specialists in oncology/pathology account management and new business development. Responsibilities included: yearly/monthly sales forecasting and attainment, budgeting, sales training, professional development and special marketing projects within the corporate office.Key Team Achievements:• Increased Sales by 464% with an additional $17M over 2002-2004 period, to a run rate of $21M annually• Regional Manager of the Year & President’s Club 2003, 2004

Us

Executed marketing strategy for flow cytometry, cytogenetics, immunohistochemistry, FISH and PCR testing services US LABS provided to the Oncology and Anatomic Pathology marketplace. Monitored test volumes and product performance associated with product lines while coordinating efforts with laboratory and medical staff to ensure quality and turnaround time expectations were achieved. Worked in conjunction with corporate and field sales management team to prepare and present technical training materials on key product offerings and consulted outside advertising agency, printers and vendors to produce and distribute sales and marketing materials. Planned and managed strategic tradeshow participation and booth management. 2002 Achievements: Successfully launched the TargetGene FISH-panel product line for Lymphoma (NHL), Leukemia, Multiple Myeloma and MDS. Consulted with key medical oncology and pathology thought-leaders to develop the strategy; ultimately changing the diagnostics paradigm for hematopoietic disorders and capturing significant market share from the competition.

Us

As one of the first five sales representatives, helped launch US LABS into the National Anatomic Pathology Marketplace. Developed and implemented a strategic sales plan to capture market share; assisted in creating all sales training materials needed for customer proposals, territory management, logistics and case management during the initial phase.2001 Achievements: President’s Club

Tucson, Arizona, Us

Responsible for key account management of Top 50 Cancer Centers in the New York City metro area, growing new business, protecting existing customers and developing strategic relationships with thought leaders in the industry. Accounts included: Columbia University, NYU Medical, Mount Sinai Medical, Memorial Sloan Kettering, New York Presbyterian Medical/Weil-Cornell. Participated in regional & national society, professional and industry meetings. Maximized territory performance through capital equipment sales and increased consumable reagent sales within the hospital, university, commercial and pharmaceutical arena. Consulted pathologists and administration on new technologies, immunohistochemistry, special stains and FISH menu, quality management and improved patient care.1999 Achievements: President's Club1998 Achievements: President's Club

Nz

A leading advertising agency in the United States and Canada specializing in corporate, business to business advertising programs throughout North America generating over $60M in revenue annually (as of 1998). Starting as one of the first sales representatives for the company and one year later promoted to Sales Manager overseeing a staff of 10-12 sales representatives and national sales campaigns. Responsibilities included: field sales management, forecasting, commission structure development, expense management, sales training and professional development.

Executive Leadership Development Program, Business Administration And Management, General

Executive Finance

Bachelor Of Arts, French, Spanish, Business

Faculté De Lettres, Institut Commercial De Nancy (Artem Business School)

Education record